• OPEN AN ACCOUNT
Indian Indices
Sensex
74,781.76 -120.83
( -0.16%)
Global Indices
Nasdaq
52,596.82 511.72
(0.98%)
Dow Jones
7,678.62 65.92
(0.87%)
Hang Seng
63,517.44 -493.90
(-0.77%)
Nikkei 225
10,650.44 41.52
(0.39%)
Forex
USD-INR
95.45 0.39
(0.41%)
EUR-INR
110.95 0.35
(0.32%)
GBP-INR
129.16 0.36
(0.28%)
JPY-INR
0.62 0.00
(0.09%)

EQUITY - MARKET SCREENER

Laurus Labs Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
540222
INE947Q01028
97.2036584
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
LAURUSLABS
122
106460.42
EPS(TTM)
Face Value()
Div & Yield %
16.15
2
0.1
 

glaxosmithkline pharma ltd
Board of Nirlon recommends final dividend
May 25,2026
Nirlon announced that the Board of Directors of the Company at its meeting held on 25 May 2026, inter alia, have recommended the final dividend of Rs 15 per equity Share (i.e. 150%) , subject to the approval of the shareholders.